Lilly Claims Proof Of Concept For Neutralizing Antibodies In COVID-19 Therapy

 
• By Joseph Haas
  
Coronavirus 2019-nCoV Blood Sample. Corona virus outbreaking. Epidemic virus Respiratory Syndrome. China
Lilly is advancing a COVID-19 therapy derived from a patient's blood sample
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip